Critical Limb Ischemia

About two-thirds of adults with severe critical limb ischemia treated with a transcatheter deep venous arterialization system achieved amputation-free survival at 6 months, according to data from the PROMISE II trial.

Effectiveness of best available surgical treatment and best available endovascular treatment in adults with CLI.

CHICAGO — In patients with critical limb ischemia, surgical revascularization was superior to endovascular revascularization if there was an adequate saphenous vein conduit, according to the results of the anticipated BEST-CLI trial.

A sirolimus-eluting balloon was associated with high rates of amputation-free survival and wound healing and low rates of target lesion revascularization in patients with critical limb ischemia and long lesions, researchers reported.

In patients with severe critical limb ischemia treated with a transcatheter deep venous arterialization system, about two-thirds achieved amputation-free survival at 6 months, according to new data from the PROMISE II trial.

Patient-reported outcome measures that assess a range of relevant domains such as health status and quality of life are vital for the comprehensive management of peripheral artery disease, according to a new scientific statement.

Transit Scientific announced the FDA cleared its support catheter platform for coronary use.

A novel, interdisciplinary limb salvage team reevaluating severe cases of critical limb ischemia avoided amputation for 75% of patients 180 days after revascularization, according to findings from a small study.

Amputation is too often the result for Black patients with critical limb ischemia, and much work must be done to overcome systemic inequities, a speaker said during the International Symposium on Endovascular Therapy.

In patients with critical limb ischemia, CT-derived fractional flow reserve often detected silent coronary ischemia, and selective revascularization of those diagnosed with it improved outcomes, according to a presentation.